97331599

Information

• Trademark
• 97331599

• Source

• Serial Number

  97331599

• International Classifications

  • 35 - Advertising
  • 36 - Insurance
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services
  • 45 - Legal services

• Filing Date

  March 25, 2022
  2 years ago

• Transaction Date

  March 26, 2024
  2 months ago

• Status Date

  March 26, 2024
  2 months ago

• Published for Opposition Date

  January 30, 2024
  4 months ago

• Location Date

  March 26, 2024
  2 months ago

• First Use Anywhere Date

  March 24, 2022
  2 years ago

• First Use In Commerce Date

  March 24, 2022
  2 years ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  GLUECK, CHRISTOPHER N

• Attorney Name

  Robin Lightner Maisashvili

  Law Office Assigned Location Code

  M30

• Owners

  • THE UNIVERSITY OF TEXAS SYSTEM

Case File Statements

• GS0411: (Based on Intent to Use) Educational services, namely, conducting programs, seminars, lectures and workshops in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; educational services, namely, developing and disseminating educational materials for others in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; arranging and conducting of training courses concerning research and development in the fields of cancer, autoimmune diseases, immunobiology and immunotherapy
• DM0000: The mark consists of a solid red circle with a solid dark grey square intersecting it at the upper left corner, a solid light grey square intersecting it at the upper right corner, and a dark grey square outline intersecting it at the lower right corner, and in the background, a red square outline surrounds the red circle and light grey square with the solid dark grey square and dark grey square outline extending beyond the borders of the red square outline. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
• GS0361: (Based on Use in Commerce) Charitable fundraising services
• CC0000: The color(s) red and grey is/are claimed as a feature of the mark.
• GS0351: (Based on Intent to Use) Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
• GS0451: (Based on Intent to Use) Providing patient advocate services in the treatment of diseases and disorders utilizing immunotherapy
• GS0441: (Based on Intent to Use) Medical services; Dispensing of pharmaceuticals; Medical and pharmaceutical consultation; Medical services relating to cancer; Dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, medical counseling; medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic testing, monitoring and reporting services; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical services, namely, treatment in the field of oncology and related health problems and diseases; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment; medical analysis services, namely, analysis of tumors, cancer or equivalent medical conditions
• GS0421: (Based on Use in Commerce) Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer

Case File Event Statements

• 3/26/2024 - 2 months ago

  22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 1/30/2024 - 4 months ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/30/2024 - 4 months ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/10/2024 - 4 months ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/28/2023 - 5 months ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/4/2023 - 6 months ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/4/2023 - 6 months ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/4/2023 - 6 months ago

  15 - ASSIGNED TO LIE Type: ALIE

• 6/29/2023 - 11 months ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/3/2023 - a year ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/3/2023 - a year ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/3/2023 - a year ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/28/2023 - a year ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/28/2023 - a year ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/28/2023 - a year ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/29/2022 - a year ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/29/2022 - a year ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/29/2022 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/25/2022 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/1/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 3/31/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/29/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP